Medical Oncologist
CION Cancer Clinics
Bridging to a liver transplant with TACE | CION Cancer Clinics
Bridging means using TACE to keep liver cancer from growing beyond the limits for a transplant while you wait for a liver. It controls the tumour; it does not replace the transplant. It is repeated only as often as scans and liver function allow. This page explains how bridging fits the transplant pathway, the other options, who it does not suit and what to ask. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
MI
Medically reviewed by Dr. Mohammed ImaduddinConsultant Surgical Oncologist · MBBS, MS (General Surgery), MCh (Surgical Oncology) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does bridging to a liver transplant with TACE mean?
- How does bridging fit into the transplant journey?
- Is TACE the only way to bridge?
- Who is bridging not suitable for, and when does it stop?
- Does the type of donor change the need to bridge?
- What do families often misunderstand about bridging?
- What can this page not tell you?
- Common questions about TACE as a bridge to transplant
The short answer
What does bridging to a liver transplant with TACE mean?
Bridging means using TACE to hold liver cancer in check while you wait for a transplant. The aim is to stop the cancer growing beyond the limits that make a transplant possible, so you do not lose your place.
Why the wait matters
A liver transplant for cancer is only offered when the cancer is still small and limited to the liver. Transplant teams use agreed limits on the size and number of tumours. The most widely used are the Milan criteria: one tumour no larger than 5 cm, or up to three tumours none larger than 3 cm, with no spread into the large blood vessels or outside the liver. Waiting for a suitable liver can take time, and a cancer can grow past those limits during that wait.
What TACE does in that gap
TACE sends a chemotherapy drug into the tumour through its artery and then blocks the artery. It is done through a thin tube in the groin or wrist. In the bridging setting its job is control, not removal. The transplant remains the main treatment.
Some transplant units use slightly wider limits than Milan. Ask which limits your unit works to.The pathway
How does bridging fit into the transplant journey?
Transplant assessment
The transplant team checks the cancer, the liver, the heart and lungs, and whether a donor is available. They decide whether you can be listed or whether a family member could donate.
The bridging decision
If the wait is expected to be more than short, the team discusses TACE or another local treatment with the interventional radiologist, the doctor who treats through blood vessels.
Treatment and scans
TACE is given, then repeated scans check the tumour stays within the limits. More sessions are given if needed and if the liver copes.
The transplant
When a liver is available, the operation goes ahead. The removed liver is examined to see how much of the tumour TACE had killed.
Not sure whether this applies to you?
Ask an oncologistOther options
Is TACE the only way to bridge?
No. Teams choose the bridge that fits the tumour, its position and how well the liver is working.
TACE
The most widely used bridge. It suits tumours with a clear arterial supply in a liver that is still working well.
TARE
Tiny radioactive beads placed through the artery. It may be considered when a vein is partly blocked or when the tumour is spread through one part of the liver.
Ablation
Heat or cold delivered through a needle into a small tumour. It needs the tumour to be small and in a place the needle can safely reach.
Focused radiotherapy
Precise radiation over a few sessions. Some centres use it when other bridges are not suitable.
Not every centre offers every option. Ask which ones your team can provide.Limits
Who is bridging not suitable for, and when does it stop?
Bridging is only useful for someone who can realistically have a transplant. If a person is not a transplant candidate, TACE may still be offered, but for a different aim.
When TACE is not the right bridge
It is avoided when the liver is failing badly, when the main vein into the liver is blocked by tumour, or when the kidneys cannot handle the contrast dye. In these situations another bridge, or no bridge, may be safer.
When the plan changes
If the scans show the cancer growing beyond the unit's limits despite treatment, or spreading outside the liver, the transplant team may take you off the list. That is one of the hardest conversations in liver cancer care. It is based on the evidence that a transplant in that situation carries a high risk of the cancer returning in the new liver. Your team will explain what treatment is still possible.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Does the type of donor change the need to bridge?
Deceased donor
Living donor
The liver comes through the state waiting list, in Telangana through Jeevandan
Part of a healthy family member's liver is used
The wait is uncertain and can be long
The date can usually be planned once the donor is cleared
Bridging is more often needed
Bridging may be used while the donor is assessed
No risk to a family member
The donor has a major operation with its own risks
Commonly believed
What do families often misunderstand about bridging?
"If TACE is working well, we can skip the transplant."
TACE controls the tumour but rarely removes all of it, and it does nothing for the damaged liver that caused the cancer. The transplant treats both. Your team will tell you if the plan changes.
"TACE will damage the liver and spoil the transplant."
The liver that is treated is the one being replaced. The team does watch liver function closely, because a failing liver before transplant makes the operation riskier.
"Being on the list means the transplant is certain."
Listing means you are eligible today. The cancer, the liver and your fitness are reviewed throughout the wait, and any of them can change the plan.
"More TACE sessions means better protection."
Each session strains the liver. Teams give only as many as the scans show are needed, and space them to let the liver recover.
Being straight with you
What can this page not tell you?
This page cannot tell you whether you are a transplant candidate, whether you need a bridge, or how the cancer will behave after a transplant. Those depend on your scans, your liver and your transplant team's assessment.
Questions worth asking
Ask which limits the unit uses to list someone. Ask how long the wait is likely to be, and whether a living donor is an option in your family. Ask why TACE was chosen as the bridge rather than another option, how often scans will be done, and what result would make the team change the plan. Ask how each session will be billed, and whether your scheme or insurance covers bridging and the transplant separately.
Questions we are asked
Common questions about TACE as a bridge to transplant
How many TACE sessions are given while waiting?
There is no fixed number. It depends on how long the wait lasts and how the tumour responds on the scans. Some people need only one session. Others need repeats spaced through a long wait. The liver's condition before each session decides whether another is safe.
Can TACE bring a cancer back within the limits?
Sometimes. Using treatment to shrink a cancer that is just outside the limits is called downstaging. Some transplant units accept people who were downstaged successfully, and others do not. Ask your unit directly whether they consider it.
Does bridging delay the transplant itself?
It should not. The transplant goes ahead when a suitable liver is ready. If a session has just been given, the team may check that you have recovered from its reaction first, but a planned TACE is not a reason to turn a liver down.
What if my father is too old for a transplant?
Age alone does not decide it. Fitness, heart and lung health, and other illnesses matter more. If he is not a candidate, TACE may still be offered to control the cancer, with a different aim. His team can explain what that aim is.
Who decides on bridging, the transplant team or the radiologist?
Usually both, at a joint meeting with liver doctors, transplant surgeons, oncologists and interventional radiologists. The transplant team sets the goal and the radiologist judges whether TACE can safely deliver it. You should be told what was decided and why.
Can a family member donate if they have diabetes?
Donors are assessed carefully for their own safety, and conditions such as diabetes, fatty liver or heart disease can rule someone out. Only the transplant team's assessment can answer this. A family member should never feel pressured to donate.
Are the side effects of TACE different while waiting for a transplant?
The reaction is similar: fever, pain and feeling sick for a few days, called post-embolisation syndrome. People with a weaker liver may take longer to recover. Report yellowing skin, belly swelling or confusion to the team the same day.
Is bridging covered by Aarogyasri or insurance?
TACE is often covered as part of an approved liver cancer plan under Aarogyasri, CGHS, ECHS, EHS or cashless insurance. A transplant is approved separately and usually has its own conditions. Ask the billing desk to check both before treatment starts.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Surgery for liver cancer
- American Cancer Society — Embolization therapy for liver cancer
- NHS — Liver transplant
- National Cancer Institute — Liver cancer treatment (PDQ), patient version
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Waiting for a transplant and been told about TACE?
Tell us what the scans have shown so far and we will help you reach the right specialist to talk it through. One helpline serves every CION centre.